Product NDC: | 0942-9206 |
Proprietary Name: | CPD |
Non Proprietary Name: | Anticoagulant Citrate Phosphate Dextrose (CPD) |
Active Ingredient(s): | 188; 1.61; 140; 1.66 mg/63mL; g/63mL; mg/63mL; g/63mL & nbsp; Anticoagulant Citrate Phosphate Dextrose (CPD) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0942-9206 |
Labeler Name: | Fenwal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BN170401 |
Marketing Category: | NDA |
Start Marketing Date: | 20070301 |
Package NDC: | 0942-9206-01 |
Package Description: | 63 mL in 1 BAG (0942-9206-01) |
NDC Code | 0942-9206-01 |
Proprietary Name | CPD |
Package Description | 63 mL in 1 BAG (0942-9206-01) |
Product NDC | 0942-9206 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Anticoagulant Citrate Phosphate Dextrose (CPD) |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070301 |
Marketing Category Name | NDA |
Labeler Name | Fenwal, Inc. |
Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
Strength Number | 188; 1.61; 140; 1.66 |
Strength Unit | mg/63mL; g/63mL; mg/63mL; g/63mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |